5:28 PM ET
8-K
Capital Raise
PAVmed Capital Raise of $15M
PAVmed's subsidiary, Lucid Diagnostics Inc., completed a private placement of 15,000 shares of Series C Convertible Preferred Stock to accredited investors. The offering generated gross proceeds of $15.0 million at a purchase price of $1,000 per share. Lucid Diagnostics also entered into a registration rights agreement to facilitate the resale of common stock issuable upon conversion of the preferred shares.
- Value
- $15M